Concomitant Dosimetry During Radionuclide Peptide Therapy with 177-Lu-DOTA-tate and 177-Lu-Lanreotide

被引：0
|
作者：
Heute, D. R. [1 ]
Dobrozemsky, G. [1 ]
Traub, T. [1 ]
Warwitz, B. [1 ]
von Guggenberg, E. [1 ]
Gabriel, M. [1 ]
Virgolini, I. [1 ]
机构：
[1] Med Univ Innsbruck, A-6020 Innsbruck, Austria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S202 / S202
页数：1
相关论文
共 50 条
  • [21] Re-treatment with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE of patients with progressive neuroendocrine neoplasm
    Durma, Adam Daniel
    Saracyn, Marek
    Kolodziej, Maciej
    Jozwik-Plebanek, Katarzyna
    Mroz, Adrianna
    Kapusta, Waldemar
    Dmochowska, Beata
    Kaminski, Grzegorz
    NUCLEAR MEDICINE REVIEW, 2023, 26 : 143 - 152
  • [22] Peptide receptor radionuclide therapy with 177Lu-DOTA-octreotate: dosimetry, nephrotoxicity, and the effect of hematological toxicity on survival
    Loeser, Anastassia
    Schwarzenboeck, Sarah M.
    Heuschkel, Martin
    Willenberg, Holger S.
    Krause, Bernd J.
    Kurth, Jens
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (03) : 236 - 246
  • [23] Obtainment of 177Lu-DOTA-LANREOTIDE for in vivo studies
    Nevares, Noemi
    Jimenez, Yarissa Villareal
    Deluca, Gustavo
    Zapata, Miguel
    Perez, Juan
    Rojo, Ana
    Crudo, Jose L.
    NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (06) : 697 - 697
  • [24] The technologist role in 177Lu dosimetry for PRRT (Peptide Receptor Radionuclide Therapy)
    Leoni, E.
    Filice, A.
    Palmieri, A.
    Ghiraldini, G.
    Fioroni, F.
    Grassi, E.
    Cola, S.
    Versari, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S850 - S851
  • [25] Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
    Anna Sundlöv
    Johan Gustafsson
    Gustav Brolin
    Nadja Mortensen
    Rebecca Hermann
    Peter Bernhardt
    Johanna Svensson
    Michael Ljungberg
    Jan Tennvall
    Katarina Sjögreen Gleisner
    EJNMMI Physics, 5
  • [26] Dosimetry in Lu-177-DOTATATE peptide receptor radionuclide therapy: a systematic review
    Nautiyal, Amit
    Michopoulou, Sofia
    Guy, Matt
    CLINICAL AND TRANSLATIONAL IMAGING, 2024, 12 (02) : 157 - 175
  • [27] Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
    Sundlov, Anna
    Gustafsson, Johan
    Brolin, Gustav
    Mortensen, Nadja
    Hermann, Rebecca
    Bernhardt, Peter
    Svensson, Johanna
    Ljungberg, Michael
    Tennvall, Jan
    Gleisner, Katarina Sjogreen
    EJNMMI PHYSICS, 2018, 5
  • [28] Dosimetry in Lu-177-DOTATATE peptide receptor radionuclide therapy: a systematic review
    Amit Nautiyal
    Sofia Michopoulou
    Matt Guy
    Clinical and Translational Imaging, 2024, 12 : 157 - 175
  • [29] Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumors
    Jiang, Yuanyuan
    Liu, Qingxing
    Wang, Guochang
    Sui, Huimin
    Wang, Rongxi
    Wang, Jiarou
    Zhang, Jingjing
    Zhu, Zhaohui
    Chen, Xiaoyuan
    THERANOSTICS, 2022, 12 (15): : 6437 - 6445
  • [30] Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
    Staanum, Peter Frohlich
    Frellsen, Anders Floor
    Olesen, Marie Louise
    Iversen, Peter
    Arveschoug, Anne Kirstine
    EJNMMI PHYSICS, 2021, 8 (01)
12345